NCT04410419

Brief Summary

The goal of this study is to evaluate the feasibility of conducting a large study that would assess the safety of carbohydrate drinks (i.e. juice) prior to elective colorectal surgery in patients with type 2 diabetes. Traditionally, prior to surgeries involving a general anesthetic, patients have been told not to eat or drink anything after midnight due to the risk of aspiration. More recent research have shown that it is safe to have clear fluids up to 2 hours before an operation and this is reflected in the current anesthesia clinical guidelines. Moreover, it has been shown that subjecting patients to a state of starvation causes stress on the body that may lead to complications such as poor wound healing, infections, and delayed return to bowel function. A sugar drink before surgery has been shown to be beneficial and can lead to decreased complication rates and decreased length of stay after surgery. However, it is currently not known if it is safe for patients with type 2 diabetes to have a sugar drink before their surgery since they have trouble processing sugars and a subset of patients with diabetes are at increased risk of aspiration due to delayed stomach emptying. This feasibility study is designed to answer the question of whether a large scale trial can be conducted examining the benefits of a pre-operative sugar drink in patients with type 2 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

May 22, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 1, 2020

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

August 21, 2025

Status Verified

August 1, 2025

Enrollment Period

6.8 years

First QC Date

May 22, 2020

Last Update Submit

August 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean difference of preoperative glucose between the two groups

    Examined in a non-inferiority fashion with NI margin set as 2mmol/L

    Pre-operative

Secondary Outcomes (6)

  • Composite outcome of diabetes-related complications

    Within 30 days of surgery or to discharge

  • length of stay

    Within 30 days of surgery or to discharge

  • Surgical site infection

    Within 30 days of surgery or to discharge

  • Postoperative complications using the Clavien Dindo scale

    Within 30 days of surgery or to discharge

  • Post-operative serum blood glucose concentration

    Within 30 days of surgery or to discharge

  • +1 more secondary outcomes

Study Arms (2)

Standard Care

NO INTERVENTION

Standard care for patients with diabetes pre-operatively .

Carbohydrate drink

EXPERIMENTAL

Carbohydrate drink containing 40g of carbohydrate to be consumed three hours prior to surgery

Dietary Supplement: Pre-operative carbohydrate drink

Interventions

Carbohydrate drink containing 40g of carbohydrate to be consumed three hours prior to surgery

Carbohydrate drink

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adult (\>=18 years of age) patients with an established diagnosis of type 2 diabetes mellitus undergoing elective colorectal surgery at the University of Alberta Hospital, the Grey Nuns Hospital, the Royal Alexandra Hospital or the Misericordia Hospital will be eligible. Only patients treated with diet or oral hypoglycemic agents will be included.

You may not qualify if:

  • Subjects \<18 years of age, and those on insulin therapy preoperatively will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta Hospital

Edmonton, Alberta, T6G 2B7, Canada

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2020

First Posted

June 1, 2020

Study Start

March 1, 2018

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

August 21, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations